Middle Cerebellar Peduncle Width—A Novel MRI Biomarker for FXTAS?
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a severe neurodegenerative movement disorder affecting over 40% of male and 16% of female FMR1 premutation carriers over the age of 50. However, there is a lack of prognostic biomarkers to aid early diagnosis and treatment planning. Therefore, t...
Main Authors: | Annie L. Shelton, Jun Y. Wang, Emily Fourie, Flora Tassone, Anna Chen, Lauren Frizzi, Randi J. Hagerman, Emilio Ferrer, David Hessl, Susan M. Rivera |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2018.00379/full |
Similar Items
-
Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS
by: Marwa Zafarullah, et al.
Published: (2023-08-01) -
Neurodegeneration of White and Gray Matter in the Hippocampus with FXTAS
by: Maryam Kargar, et al.
Published: (2023-12-01) -
Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
by: Maria Jimena Salcedo-Arellano, et al.
Published: (2023-08-01) -
Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins
by: Eleonora Napoli, et al.
Published: (2018-08-01) -
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)
by: Ellery Santos, et al.
Published: (2023-12-01)